Anzeige
Mehr »
Login
Samstag, 29.03.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Ad-hoc-News: Wieder Verdopplung? Montag massiver Turnaround und komplette Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P8F1 | ISIN: CA74764Y2050 | Ticker-Symbol: 0K91
Tradegate
28.03.25
20:52 Uhr
7,500 Euro
-0,550
-6,83 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
QUANTUM BIOPHARMA LTD Chart 1 Jahr
5-Tage-Chart
QUANTUM BIOPHARMA LTD 5-Tage-Chart
RealtimeGeldBriefZeit
7,8008,05010:52
7,9508,15028.03.

Aktuelle News zur QUANTUM BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrQuantum Biopharma Ltd. - 20-F, Annual and transition report of foreign private issuers2
FrQuantum BioPharma stock soars on removal of uncertainty related to going concern2
FrQuantum BioPharma reports progress in drug trials6
FrQuantum BioPharma meldet Fortschritte bei Medikamentenstudien3
FrQuantum Biopharma Ltd.: Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern216Completion of unbuzzdTM Clinical Trial and Multiple Sclerosis Drug Lucid-21-302 Phase 1 Trial Advance Company's Pipeline of Products and Assets TORONTO, ONTARIO / ACCESS Newswire / March 28, 2025 /...
► Artikel lesen
FrQuantum BioPharma reports FY results4
FrQuantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern181TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), has reported its financial and operational results...
► Artikel lesen
QUANTUM BIOPHARMA Aktie jetzt für 0€ handeln
DoQuantum Biopharma Ltd: Quantum Biopharma appoints Lynch as director2
DoQuantum BioPharma beruft Terry Lynch in den Vorstand9
DoQuantum BioPharma adds Terry Lynch to its board4
DoQuantum Biopharma Announces Leading Crusader Against Naked Short Selling and Stock Manipulation, Terry Lynch Elected to Board of Directors243TORONTO, March 27, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), is pleased to announce the appointment of Terry Lynch...
► Artikel lesen
MiQuantum Biopharma Ltd: Quantum Biopharma licensee expands unbuzzd line5
MiQuantum BioPharma Licensee Celly Nutrition Expands unbuzzd Alcohol Detox Product Lineup for Retail Sales9
20.03.Quantum Biopharma Ltd: Quantum Biopharma boosts crypto holdings to $3.5M(U.S.)17
20.03.Quantum BioPharma Continues to Grow Its Crypto Assets and Diversify Its Treasury With the Purchase of Another USD $1,500,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies144TORONTO, March 20, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), is pleased to announce that after receiving approval...
► Artikel lesen
20.03.Quantum Biopharma Ltd. - 6-K, Report of foreign issuer1
17.03.Quantum Biopharma Ltd: Quantum Biopharma does not say way trading is up15
17.03.Quantum BioPharma Ltd.: Quantum BioPharma Unaware of Any Material Change416Toronto, Ontario--(Newsfile Corp. - March 17, 2025) - At the request of the Canadian Investment Regulatory Organization, Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (the "Company")...
► Artikel lesen
08.03.Quantum Biopharma Ltd: Quantum Biopharma grants option to replace warrants39
08.03.Quantum BioPharma Ltd.: Quantum BioPharma Provides Corporate Update765Toronto, Ontario--(Newsfile Corp. - March 7, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (the "Company"), a biopharmaceutical company dedicated to building a portfolio of...
► Artikel lesen
Seite:  Weiter >>
124 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,4,3